One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients
Online-Only Appendix
Files in this Data Supplement:
This Article
-
Diabetes Care May 2009 vol. 32 no. 5 762-768
- AbstractFree
- Full Text
- Full Text (PDF)
- » Online-Only Appendix
Current Issue
From the Cover
- Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
- Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program
- High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects
- Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation
